We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
More than 20 pharmaceutical companies on Wednesday launched a project termed Access Accelerated to tackle non-communicable diseases (NCDs) such as cancer and diabetes in low and lower-middle income countries.